201 related articles for article (PubMed ID: 20550660)
1. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.
Di Somma S; Magrini L; Pittoni V; Marino R; Mastrantuono A; Ferri E; Ballarino P; Semplicini A; Bertazzoni G; Carpinteri G; Mulè P; Pazzaglia M; Shah K; Maisel A; Clopton P
Crit Care; 2010; 14(3):R116. PubMed ID: 20550660
[TBL] [Abstract][Full Text] [Related]
2. Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study.
Di Somma S; Marino R; Zampini G; Magrini L; Ferri E; Shah K; Clopton P; Maisel AS
Clin Chem Lab Med; 2015 Feb; 53(3):507-13. PubMed ID: 25252752
[TBL] [Abstract][Full Text] [Related]
3. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S;
Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064
[TBL] [Abstract][Full Text] [Related]
6. Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
Omar HR; Guglin M
Int J Cardiol; 2016 Oct; 221():1116-22. PubMed ID: 27467969
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
[TBL] [Abstract][Full Text] [Related]
10. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
[TBL] [Abstract][Full Text] [Related]
11. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.
Park S; Cho GY; Kim SG; Hwang YI; Kang HR; Jang SH; Kim DG; Song YR; Bae YA; Jung KS
Crit Care; 2009; 13(3):R70. PubMed ID: 19445682
[TBL] [Abstract][Full Text] [Related]
13. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
14. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
15. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of BNP Reduction During Hospitalization in Patients With Acute Heart Failure.
Kagiyama N; Kitai T; Hayashida A; Yamaguchi T; Okumura T; Kida K; Mizuno A; Oishi S; Inuzuka Y; Akiyama E; Suzuki S; Yamamoto M; Shimizu A; Urakami Y; Toki M; Aritaka S; Matsumoto K; Nagano N; Yamamoto K; Matsue Y
J Card Fail; 2019 Sep; 25(9):712-721. PubMed ID: 30965102
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes.
Minami Y; Kajimoto K; Sato N; Hagiwara N; Takano T; Mebazaa A;
Eur J Intern Med; 2016 Jun; 31():41-9. PubMed ID: 26880295
[TBL] [Abstract][Full Text] [Related]
19. Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure.
Anegawa E; Takahama H; Nishimura K; Onozuka D; Irie Y; Moriuchi K; Amano M; Okada A; Amaki M; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Izumi C
Open Heart; 2021 May; 8(1):. PubMed ID: 34001654
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients.
Stenner E; Buiatti A; Barbati G; Merlo M; Sinagra G; Biasioli B
Clin Lab; 2012; 58(5-6):585-9. PubMed ID: 22783593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
